Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today ...
News-Medical.Net on MSN
GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes
In youth newly diagnosed with type 2 diabetes, GLP-1–based therapies, including semaglutide and tirzepatide, achieved similar ...
Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic ...
Three-year follow-up data from FIREFLY-1 demonstrates durable responses with evidence of clinical stability off treatment, with the potential for ...
ROME, NOV 10 - The use of psychiatric drugs in minors in Italy more than doubled in the eight years from 2016 to 2024, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback